Few have appreciated the wealth of information to be gained by the study of blood more than Maxwell Myer Wintrobe (1906 to 1986). He cited poets, including John Donne’s "pure and eloquent blood" and Goethe’s "Blood is a juice of a very special kind"; but he added that "It is for the scientist that the blood has been especially eloquent.” It has been over 70 years since Wintrobe wrote the first edition of Clinical Hematology (1942); and at the time, he was uncertain if it would have much readership owing to the priorities of World War II. His objective was "to bring together the accumulated information in the field of hematology in a systematic and orderly form." He felt the book should be "comprehensive, complete, and authoritative." He emphasized the importance of "an accurate diagnosis as a prerequisite to efficacious treatment." His goals were to link science to the clinical practice of hematology and to provide the best therapy possible for an individual patient.
John P. Greer, M.D.
Dr. Greer is the Professor of Medicine & Pediatrics and Clinical Director, Hematology and Stem Cell Transplantation at Vanderbilt University Medical Center. He is a hematologist/oncologist who specializes in hematological malignancies and stem cell transplantation. His research interests are in the clinicopathologic description of hematologic neoplasms and in the development of therapeutic strategies to treat these disorders. He has an expertise in T cell lymphomas and has a joint cutaneous lymphoma clinic with Dr. John Zic in dermatology. Dr. Greer's extramural activities include Chief Editor for Wintrobe's Clinical Hematology (12th edition, 2009) and member of the Lymphoma Committee for ECOG. His research interests are in the clinicopathologic descriptions of hematologic neoplasms and in the development of therapeutic strategies to treat those disorders. Specific entities he has helped recognize include anaplastic large cell lymphoma, T-cell-rich B-cell lymphoma, and natural killer-like T-cell lymphoma/leukemia.
Wintrobe’s Clinical Hematology, 13th Edition, reviews the science, the methods of diagnosis, and the evidence for the basis of therapeutic decisions.
Seventy-four new authors have completely revised old chapters, in addition to adding new chapters, all of which reflect Wintrobe’s commitment to propelling the current state of hematology into the future. The artwork has been extensively redrawn for color and consistency and a new online presence brings this text into the 21st century, providing readers with a way to interact with the very latest in hematology.
This latest edition also includesnew and up-to-date information about the process and application of gene therapy and immunotherapy. The authors explore the topics of stem cell transplantation for both malignant and benign disorders, graft versus host disease, and the importance of long-term follow-up of transplantation survivors.
Online, interactive companion – with regular content updates – includes all text, figures, a reference list for each chapter, and two appendices
Increased emphasis on molecular genetics and flow cytometry
Expanded number of hematopathology illustrations
More in-depth treatment of transplantation
Pertinent updates posted online in a timely manner